Biotech · Private company

Clene Nanomedicine

Track this companyFree. Adds Clene Nanomedicine to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline7

HEALEY ALS Platform Trial - Regimen C CNM-Au8PHASE2_PHASE3 · COMPLETED · started Jul 30, 2020ClinicalTrials.gov NCT04414345 · fetched Nov 12, 2026
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)PHASE2 · WITHDRAWN · started Mar 1, 2020ClinicalTrials.gov NCT03843710 · fetched Nov 12, 2026
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.PHASE2 · COMPLETED · started Dec 19, 2019ClinicalTrials.gov NCT03993171 · fetched Nov 12, 2026
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's DiseasePHASE2 · COMPLETED · started Dec 19, 2019ClinicalTrials.gov NCT03815916 · fetched Nov 12, 2026
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple SclerosisPHASE2 · TERMINATED · started Nov 23, 2018ClinicalTrials.gov NCT03536559 · fetched Nov 12, 2026
Intermediate Expanded Access Protocol CNMAu8.EAP04TEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT06408727 · fetched Nov 12, 2026
Intermediate Expanded Access Protocol CNMAu8.EAP03TEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT04081714 · fetched Nov 12, 2026
Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALSAVAILABLEClinicalTrials.gov NCT05281484 · fetched Nov 12, 2026